> top > docs > PMC:1064895 > spans > 18600-19332 > annotations

PMC:1064895 / 18600-19332 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T13365 480-490 Gene_expression denotes production
T13364 474-479 Protein denotes IL-17
T13363 459-470 Negative_regulation denotes inhibitions
T13362 449-458 Regulation denotes dependent
T13361 413-423 Gene_expression denotes production
T13360 407-412 Protein denotes IL-17
T13359 393-403 Negative_regulation denotes inhibition
T13358 220-225 Protein denotes IL-17
T13357 210-216 Regulation denotes effect
T13356 80-89 Localization denotes secretion
T13355 74-79 Protein denotes IL-17
T13354 56-69 Negative_regulation denotes downregulated
T13353 4-15 Protein denotes calcineurin
T13338 474-479 Protein denotes IL-17
T13337 407-412 Protein denotes IL-17
T13336 220-225 Protein denotes IL-17
T13335 74-79 Protein denotes IL-17
T13334 4-15 Protein denotes calcineurin
R7281 T13353 T13354 causeOf calcineurin,downregulated
R7282 T13355 T13356 themeOf IL-17,secretion
R7283 T13356 T13354 themeOf secretion,downregulated
R7284 T13360 T13361 themeOf IL-17,production
R7285 T13361 T13359 themeOf production,inhibition
R7286 T13364 T13365 themeOf IL-17,production
R7287 T13365 T13363 themeOf production,inhibitions

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T13974 480-490 Gene_expression denotes production
T13973 459-470 Negative_regulation denotes inhibitions
T13972 413-423 Gene_expression denotes production
T13971 393-403 Negative_regulation denotes inhibition
T13970 16-26 Negative_regulation denotes inhibitors
T13969 210-216 Regulation denotes effect
T13968 56-69 Negative_regulation denotes downregulated
T13967 80-89 Localization denotes secretion
T13956 474-479 Protein denotes IL-17
T13955 407-412 Protein denotes IL-17
T13954 220-225 Protein denotes IL-17
T13953 74-79 Protein denotes IL-17
T13952 4-15 Protein denotes calcineurin
R7593 T13952 T13970 themeOf calcineurin,inhibitors
R7594 T13953 T13967 themeOf IL-17,secretion
R7595 T13954 T13969 themeOf IL-17,effect
R7596 T13955 T13972 themeOf IL-17,production
R7597 T13956 T13974 themeOf IL-17,production
R7604 T13967 T13968 themeOf secretion,downregulated
R7605 T13972 T13971 themeOf production,inhibition
R7606 T13974 T13973 themeOf production,inhibitions

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T14396 480-490 Gene_expression denotes production
T14395 459-470 Negative_regulation denotes inhibitions
T14394 413-423 Gene_expression denotes production
T14393 393-403 Negative_regulation denotes inhibition
T14392 80-89 Localization denotes secretion
T14391 16-26 Negative_regulation denotes inhibitors
T14390 56-69 Negative_regulation denotes downregulated
T14389 210-216 Regulation denotes effect
T14378 474-479 Protein denotes IL-17
T14377 407-412 Protein denotes IL-17
T14376 220-225 Protein denotes IL-17
T14375 74-79 Protein denotes IL-17
T14374 4-15 Protein denotes calcineurin
R7941 T14374 T14391 themeOf calcineurin,inhibitors
R7942 T14375 T14392 themeOf IL-17,secretion
R7943 T14376 T14389 themeOf IL-17,effect
R7944 T14377 T14394 themeOf IL-17,production
R7945 T14378 T14396 themeOf IL-17,production
R7952 T14392 T14390 themeOf secretion,downregulated
R7953 T14394 T14393 themeOf production,inhibition
R7954 T14396 T14395 themeOf production,inhibitions

biosemtest

Id Subject Object Predicate Lexical cue
T13526 152-155 UP/Q01552 denotes ibi
T13525 227-232 UMLS/C1825592 denotes evels
T13524 81-86 UMLS/C1825592 denotes ecret
T13523 152-155 UP/O95433 denotes ibi
T13522 481-497 UMLS/C1819444 denotes roduction with c
T13521 414-430 UMLS/C1819444 denotes roduction in PBM
T13516 152-155 UP/P46108 denotes ibi
T13515 87-96 UMLS/C1546773 denotes on as wel
T13514 233-239 UMLS/C0441889 denotes (Fig.
T13513 202-209 UMLS/C0298346 denotes had no
T13512 320-324 UMLS/C1299351 denotes ncen
T13509 188-197 UMLS/C0072980 denotes in and PD
T13508 253-261 UMLS/C0220825 denotes e the po
T13507 357-361 UMLS/C0178602 denotes spon
T13506 146-150 UMLS/C1370600 denotes 38 i
T13505 637-644 UMLS/C2348382 denotes on PBM
T13504 604-611 UMLS/C0449774 denotes of inh
T13503 660-668 UMLS/C0220806 denotes l inhibi
T13502 503-511 UMLS/C0220806 denotes l inhibi
T13501 683-695 UMLS/C1517004 denotes ental concen
T13499 451-465 UMLS/C1512045 denotes pendent inhibi
T13498 669-679 UMLS/C1999216 denotes ors at exp
T13497 544-554 UMLS/C1999216 denotes ors in add
T13496 512-522 UMLS/C1999216 denotes ors (Fig.
T13495 156-165 UMLS/C1999216 denotes or SB2035
T13491 152-155 UP/Q63768 denotes ibi
T13490 716-719 UMLS/C1518422 denotes erv
T13489 529-531 UMLS/C0450373 denotes e
T13488 637-644 UMLS/C1280500 denotes on PBM
T13484 11-33 UP/O88480 denotes urin inhibitors cyclos
T13483 558-569 UMLS/C0332287 denotes n to PDTC a
T13482 320-324 UMLS/C0205250 denotes ncen
T13481 152-155 UMLS/C1833235 denotes ibi
T13480 357-361 UMLS/C1114758 denotes spon
T13479 152-155 UMLS/C1150588 denotes ibi
T13478 52-57 UMLS/C0729218 denotes lso d
T13477 696-710 UMLS/C0086045 denotes rations were n
T13476 325-339 UMLS/C0086045 denotes rations, we ob
T13475 146-150 UMLS/C1150579 denotes 38 i
T13474 152-155 UMLS/C1705633 denotes ibi
T13471 320-324 UMLS/C1561957 denotes ncen
T13470 357-361 UMLS/C0869039 denotes spon
T13469 615-625 UMLS/C1628982 denotes ion. Cytot
T13468 466-477 UMLS/C1628982 denotes ions of IL-
T13467 400-410 UMLS/C1628982 denotes ion of IL-
T13466 294-304 UMLS/C1628982 denotes ion by the
T13464 320-324 UMLS/C1561958 denotes ncen
T13463 579-587 UMLS/C0251991 denotes 2 showed
T13462 383-391 UMLS/C0251991 denotes 2 for th
T13460 227-232 UMLS/C1522571 denotes evels
T13459 81-86 UMLS/C1522571 denotes ecret
T13456 599-603 UMLS/C1692345 denotes tter
T13455 146-150 UMLS/C1150553 denotes 38 i
T13454 570-574 UMLS/C0084183 denotes d LY
T13453 374-378 UMLS/C0084183 denotes d LY
T13451 648-652 UMLS/C1321301 denotes the
T13450 434-438 UMLS/C1321301 denotes here
T13447 227-232 UMLS/C0384648 denotes evels
T13446 81-86 UMLS/C0384648 denotes ecret
T13443 538-543 UMLS/C1556044 denotes nhibi
T13442 362-370 UMLS/C1706817 denotes e of PDT
T13441 214-223 UMLS/C1301751 denotes ct on IL-
T13440 627-636 UMLS/C0677881 denotes ic effect
T13439 669-679 UMLS/C0243077 denotes ors at exp
T13438 544-554 UMLS/C0243077 denotes ors in add
T13437 512-522 UMLS/C0243077 denotes ors (Fig.
T13436 156-165 UMLS/C0243077 denotes or SB2035
T13433 112-144 UP/Q00859 denotes -activated protein kinase (MAPK)
T13432 11-33 UP/Q9Y6J0 denotes urin inhibitors cyclos
T13431 312-316 UMLS/C0013227 denotes hig
T13430 362-370 UMLS/C1704632 denotes e of PDT
T13428 538-543 UMLS/C1955473 denotes nhibi
T13427 11-33 UMLS/C1562036 denotes urin inhibitors cyclos
T13426 152-155 UP/Q9NV58 denotes ibi
T13425 166-174 UMLS/C0297666 denotes 0 did, w
T13423 152-155 UP/Q04929 denotes ibi
T13422 100-104 UMLS/C0205170 denotes the
T13421 227-232 UMLS/C1623218 denotes evels
T13420 81-86 UMLS/C1623218 denotes ecret
T13417 152-155 UP/O97628 denotes ibi
T13416 720-728 UMLS/C1441672 denotes d (Fig.
T13415 344-352 UMLS/C1441672 denotes d the do
T13412 146-150 UMLS/C0752312 denotes 38 i
T13411 112-144 UMLS/C0752312 denotes -activated protein kinase (MAPK)
T13410 320-324 UMLS/C1522410 denotes ncen
T13409 529-531 UMLS/C1553636 denotes e
T13406 615-625 UMLS/C0021467 denotes ion. Cytot
T13405 466-477 UMLS/C0021467 denotes ions of IL-
T13404 400-410 UMLS/C0021467 denotes ion of IL-
T13403 294-304 UMLS/C0021467 denotes ion by the
T13401 615-625 UMLS/C0021469 denotes ion. Cytot
T13400 466-477 UMLS/C0021469 denotes ions of IL-
T13399 400-410 UMLS/C0021469 denotes ion of IL-
T13398 294-304 UMLS/C0021469 denotes ion by the
T13394 250-252 UMLS/C0319022 denotes ua
T13389 524-527 UMLS/C0349966 denotes ).
T13388 241-244 UMLS/C0349966 denotes . T
T13386 627-636 UMLS/C1511636 denotes ic effect
T13384 152-155 UP/Q64010 denotes ibi
T13382 87-96 UMLS/C1327616 denotes on as wel
T13380 281-293 UMLS/C0205370 denotes cific inhibi
T13379 87-96 UMLS/C0036536 denotes on as wel
T13376 87-96 UMLS/C0036537 denotes on as wel
T13375 152-155 UMLS/C1412886 denotes ibi
T13374 599-603 UMLS/C0445247 denotes tter
T13373 233-239 UMLS/C0456079 denotes (Fig.
T13372 152-155 UMLS/C1366876 denotes ibi
T13371 362-370 UMLS/C0871261 denotes e of PDT
T13369 34-47 UMLS/C0010592 denotes orin A and FK
T13368 312-316 UMLS/C1254351 denotes hig
T13367 696-710 UMLS/C1446561 denotes rations were n
T13366 325-339 UMLS/C1446561 denotes rations, we ob

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T13824 597-604 NN denotes pattern
T13844 730-731 -RRB- denotes )
T13843 728-730 NN denotes 4b
T13842 723-727 NNP denotes Fig.
T13841 722-723 -LRB- denotes (
T13840 713-721 VB denotes observed
T13839 709-712 RB denotes not
T13838 704-708 VB denotes were
T13837 689-703 NN denotes concentrations
T13836 676-688 JJ denotes experimental
T13835 673-675 IN denotes at
T13834 662-672 NN denotes inhibitors
T13833 653-661 JJ denotes chemical
T13832 649-652 DT denotes the
T13831 646-648 IN denotes by
T13830 641-645 NN denotes PBMC
T13829 638-640 IN denotes on
T13828 630-637 NN denotes effects
T13827 620-629 JJ denotes Cytotoxic
T13826 608-618 NN denotes inhibition
T13825 605-607 IN denotes of
T13823 592-596 JJ denotes same
T13822 588-591 DT denotes the
T13821 581-587 VB denotes showed
T13820 572-580 NN denotes LY294002
T13819 568-571 CC denotes and
T13818 563-567 NN denotes PDTC
T13817 560-562 TO denotes to
T13816 551-559 NN denotes addition
T13815 548-550 IN denotes in
T13814 537-547 NN denotes inhibitors
T13813 531-536 JJ denotes other
T13812 527-530 DT denotes The
T13811 524-525 -RRB- denotes )
T13810 522-524 NN denotes 4a
T13809 517-521 NN denotes Fig.
T13808 516-517 -LRB- denotes (
T13807 505-515 NN denotes inhibitors
T13806 496-504 JJ denotes chemical
T13805 491-495 IN denotes with
T13804 480-490 NN denotes production
T13803 474-479 NN denotes IL-17
T13802 471-473 IN denotes of
T13801 459-470 NN denotes inhibitions
T13800 444-458 JJ denotes dose-dependent
T13799 439-443 VB denotes were
T13798 433-438 EX denotes There
T13797 427-431 NN denotes PBMC
T13796 424-426 IN denotes in
T13795 413-423 NN denotes production
T13794 407-412 NN denotes IL-17
T13793 404-406 IN denotes of
T13792 393-403 NN denotes inhibition
T13791 389-392 DT denotes the
T13790 385-388 IN denotes for
T13789 376-384 NN denotes LY294002
T13788 372-375 CC denotes and
T13787 367-371 NN denotes PDTC
T13786 364-366 IN denotes of
T13785 355-363 NN denotes response
T13784 350-354 NN denotes dose
T13783 346-349 DT denotes the
T13782 337-345 VB denotes observed
T13781 334-336 PRP denotes we
T13780 332-333 -COMMA- denotes ,
T13779 318-332 NN denotes concentrations
T13778 313-317 JJ denotes high
T13777 310-312 IN denotes at
T13776 305-309 NN denotes drug
T13775 301-304 DT denotes the
T13774 298-300 IN denotes by
T13773 287-297 NN denotes inhibition
T13772 274-286 JJ denotes non-specific
T13771 271-273 IN denotes of
T13770 259-270 NN denotes possibility
T13769 255-258 DT denotes the
T13768 246-254 VB denotes evaluate
T13767 243-245 TO denotes To
T13766 240-241 -RRB- denotes )
T13765 239-240 CD denotes 3
T13764 234-238 NN denotes Fig.
T13763 233-234 -LRB- denotes (
T13762 226-232 NN denotes levels
T13761 220-225 NN denotes IL-17
T13760 217-219 IN denotes on
T13759 210-216 NN denotes effect
T13758 207-209 DT denotes no
T13757 203-206 VB denotes had
T13756 195-202 NN denotes PD98059
T13755 191-194 CC denotes and
T13754 181-190 NN denotes rapamycin
T13753 173-180 IN denotes whereas
T13752 171-172 -COMMA- denotes ,
T13751 168-171 VB denotes did
T13750 159-167 NN denotes SB203580
T13749 149-158 NN denotes inhibitor
T13748 145-148 NN denotes p38
T13747 143-144 -RRB- denotes )
T13746 139-143 NN denotes MAPK
T13745 138-139 -LRB- denotes (
T13744 131-137 NN denotes kinase
T13743 123-130 NN denotes protein
T13742 105-122 JJ denotes mitogen-activated
T13741 101-104 DT denotes the
T13740 98-100 IN denotes as
T13739 93-97 RB denotes well
T13738 90-92 RB denotes as
T13737 80-89 NN denotes secretion
T13736 74-79 NN denotes IL-17
T13735 70-73 DT denotes the
T13734 56-69 VB denotes downregulated
T13733 51-55 RB denotes also
T13732 45-50 NN denotes FK506
T13731 41-44 CC denotes and
T13730 39-40 NN denotes A
T13729 27-38 NN denotes cyclosporin
T13728 16-26 NN denotes inhibitors
T13727 4-15 NN denotes calcineurin
T13726 0-3 DT denotes The
R7441 T13728 T13726 arg1Of inhibitors,The
R7442 T13728 T13727 arg1Of inhibitors,calcineurin
R7443 T13730 T13729 arg1Of A,cyclosporin
R7444 T13730 T13731 arg1Of A,and
R7445 T13731 T13728 arg1Of and,inhibitors
R7446 T13731 T13734 arg1Of and,downregulated
R7447 T13732 T13731 arg2Of FK506,and
R7448 T13734 T13733 arg1Of downregulated,also
R7449 T13734 T13739 arg1Of downregulated,well
R7450 T13734 T13752 arg1Of downregulated,","
R7451 T13734 T13753 arg1Of downregulated,whereas
R7452 T13737 T13734 arg2Of secretion,downregulated
R7453 T13737 T13735 arg1Of secretion,the
R7454 T13737 T13736 arg1Of secretion,IL-17
R7455 T13739 T13738 arg1Of well,as
R7456 T13740 T13739 arg2Of as,well
R7457 T13744 T13742 arg1Of kinase,mitogen-activated
R7458 T13744 T13743 arg1Of kinase,protein
R7459 T13744 T13745 arg1Of kinase,(
R7460 T13746 T13745 arg2Of MAPK,(
R7461 T13747 T13745 arg3Of ),(
R7462 T13750 T13741 arg1Of SB203580,the
R7463 T13750 T13744 arg1Of SB203580,kinase
R7464 T13750 T13748 arg1Of SB203580,p38
R7465 T13750 T13749 arg1Of SB203580,inhibitor
R7466 T13750 T13751 arg1Of SB203580,did
R7467 T13751 T13740 arg2Of did,as
R7468 T13754 T13755 arg1Of rapamycin,and
R7469 T13755 T13757 arg1Of and,had
R7470 T13756 T13755 arg2Of PD98059,and
R7471 T13757 T13753 arg2Of had,whereas
R7472 T13757 T13760 arg1Of had,on
R7473 T13759 T13757 arg2Of effect,had
R7474 T13759 T13758 arg1Of effect,no
R7475 T13762 T13760 arg2Of levels,on
R7476 T13762 T13761 arg1Of levels,IL-17
R7477 T13762 T13763 arg1Of levels,(
R7478 T13764 T13763 arg2Of Fig.,(
R7479 T13764 T13765 arg1Of Fig.,3
R7480 T13766 T13763 arg3Of ),(
R7481 T13768 T13767 arg1Of evaluate,To
R7482 T13768 T13777 arg1Of evaluate,at
R7483 T13770 T13768 arg2Of possibility,evaluate
R7484 T13770 T13769 arg1Of possibility,the
R7485 T13770 T13771 arg1Of possibility,of
R7486 T13770 T13774 arg1Of possibility,by
R7487 T13773 T13771 arg2Of inhibition,of
R7488 T13773 T13772 arg1Of inhibition,non-specific
R7489 T13776 T13774 arg2Of drug,by
R7490 T13776 T13775 arg1Of drug,the
R7491 T13779 T13777 arg2Of concentrations,at
R7492 T13779 T13778 arg1Of concentrations,high
R7493 T13781 T13768 arg1Of we,evaluate
R7494 T13781 T13782 arg1Of we,observed
R7495 T13782 T13767 modOf observed,To
R7496 T13782 T13780 arg1Of observed,","
R7497 T13785 T13782 arg2Of response,observed
R7498 T13785 T13783 arg1Of response,the
R7499 T13785 T13784 arg1Of response,dose
R7500 T13785 T13786 arg1Of response,of
R7501 T13785 T13790 arg1Of response,for
R7502 T13787 T13788 arg1Of PDTC,and
R7503 T13788 T13786 arg2Of and,of
R7504 T13789 T13788 arg2Of LY294002,and
R7505 T13792 T13790 arg2Of inhibition,for
R7506 T13792 T13791 arg1Of inhibition,the
R7507 T13792 T13793 arg1Of inhibition,of
R7508 T13795 T13793 arg2Of production,of
R7509 T13795 T13794 arg1Of production,IL-17
R7510 T13795 T13796 arg1Of production,in
R7511 T13797 T13796 arg2Of PBMC,in
R7512 T13798 T13799 arg1Of There,were
R7513 T13801 T13799 arg2Of inhibitions,were
R7514 T13801 T13800 arg1Of inhibitions,dose-dependent
R7515 T13801 T13802 arg1Of inhibitions,of
R7516 T13804 T13802 arg2Of production,of
R7517 T13804 T13803 arg1Of production,IL-17
R7518 T13804 T13805 arg1Of production,with
R7519 T13807 T13805 arg2Of inhibitors,with
R7520 T13807 T13806 arg1Of inhibitors,chemical
R7521 T13807 T13808 arg1Of inhibitors,(
R7522 T13810 T13808 arg2Of 4a,(
R7523 T13810 T13809 arg1Of 4a,Fig.
R7524 T13811 T13808 arg3Of ),(
R7525 T13814 T13812 arg1Of inhibitors,The
R7526 T13814 T13813 arg1Of inhibitors,other
R7527 T13814 T13815 arg1Of inhibitors,in
R7528 T13814 T13821 arg1Of inhibitors,showed
R7529 T13816 T13815 arg2Of addition,in
R7530 T13816 T13817 arg1Of addition,to
R7531 T13818 T13819 arg1Of PDTC,and
R7532 T13819 T13817 arg2Of and,to
R7533 T13820 T13819 arg2Of LY294002,and
R7534 T13824 T13821 arg2Of pattern,showed
R7535 T13824 T13822 arg1Of pattern,the
R7536 T13824 T13823 arg1Of pattern,same
R7537 T13824 T13825 arg1Of pattern,of
R7538 T13826 T13825 arg2Of inhibition,of
R7539 T13828 T13827 arg1Of effects,Cytotoxic
R7540 T13828 T13829 arg1Of effects,on
R7541 T13828 T13838 arg1Of effects,were
R7542 T13828 T13840 arg2Of effects,observed
R7543 T13830 T13829 arg2Of PBMC,on
R7544 T13830 T13831 arg1Of PBMC,by
R7545 T13830 T13835 arg1Of PBMC,at
R7546 T13834 T13831 arg2Of inhibitors,by
R7547 T13834 T13832 arg1Of inhibitors,the
R7548 T13834 T13833 arg1Of inhibitors,chemical
R7549 T13837 T13835 arg2Of concentrations,at
R7550 T13837 T13836 arg1Of concentrations,experimental
R7551 T13840 T13838 arg2Of observed,were
R7552 T13840 T13839 arg1Of observed,not
R7553 T13840 T13841 arg1Of observed,(
R7554 T13843 T13841 arg2Of 4b,(
R7555 T13843 T13842 arg1Of 4b,Fig.
R7556 T13844 T13841 arg3Of ),(

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T13853 474-479 Protein denotes IL-17
T13852 407-412 Protein denotes IL-17
T13851 220-225 Protein denotes IL-17
T13850 74-79 Protein denotes IL-17
T13849 4-15 Protein denotes calcineurin

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T13935 474-479 http://www.uniprot.org/uniprot/Q16552 denotes IL-17
T13934 407-412 http://www.uniprot.org/uniprot/Q16552 denotes IL-17
T13933 220-225 http://www.uniprot.org/uniprot/Q16552 denotes IL-17
T13932 74-79 http://www.uniprot.org/uniprot/Q16552 denotes IL-17

GO-BP

Id Subject Object Predicate Lexical cue
T13569 145-148 http://purl.obolibrary.org/obo/GO_0004707 denotes p38
T13568 139-143 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T13567 113-137 http://purl.obolibrary.org/obo/GO_0032111 denotes activated protein kinase
T13566 113-137 http://purl.obolibrary.org/obo/GO_0030295 denotes activated protein kinase
T13565 113-137 http://purl.obolibrary.org/obo/GO_0032147 denotes activated protein kinase
T13564 113-137 http://purl.obolibrary.org/obo/GO_0034199 denotes activated protein kinase
T13563 80-89 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T13562 74-89 http://purl.obolibrary.org/obo/GO_0072615 denotes IL-17 secretion
T13561 4-15 http://purl.obolibrary.org/obo/GO_0004723 denotes calcineurin
T13560 4-15 http://purl.obolibrary.org/obo/GO_0004722 denotes calcineurin
T13548 474-490 http://purl.obolibrary.org/obo/GO_0032620 denotes IL-17 production
T13547 407-423 http://purl.obolibrary.org/obo/GO_0032620 denotes IL-17 production
T13542 474-490 http://purl.obolibrary.org/obo/GO_0032660 denotes IL-17 production
T13541 407-423 http://purl.obolibrary.org/obo/GO_0032660 denotes IL-17 production

GO-MF

Id Subject Object Predicate Lexical cue
T13867 145-148 http://purl.obolibrary.org/obo/GO_0004707 denotes p38
T13866 139-143 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T13865 113-137 http://purl.obolibrary.org/obo/GO_0030295 denotes activated protein kinase
T13864 4-15 http://purl.obolibrary.org/obo/GO_0004723 denotes calcineurin
T13863 4-15 http://purl.obolibrary.org/obo/GO_0004722 denotes calcineurin
T13861 474-479 http://purl.obolibrary.org/obo/GO_0030367 denotes IL-17
T13860 407-412 http://purl.obolibrary.org/obo/GO_0030367 denotes IL-17
T13859 220-225 http://purl.obolibrary.org/obo/GO_0030367 denotes IL-17
T13858 74-79 http://purl.obolibrary.org/obo/GO_0030367 denotes IL-17

sentences

Id Subject Object Predicate Lexical cue
T13536 620-732 Sentence denotes Cytotoxic effects on PBMC by the chemical inhibitors at experimental concentrations were not observed (Fig. 4b).
T13535 527-619 Sentence denotes The other inhibitors in addition to PDTC and LY294002 showed the same pattern of inhibition.
T13534 433-526 Sentence denotes There were dose-dependent inhibitions of IL-17 production with chemical inhibitors (Fig. 4a).
T13533 243-432 Sentence denotes To evaluate the possibility of non-specific inhibition by the drug at high concentrations, we observed the dose response of PDTC and LY294002 for the inhibition of IL-17 production in PBMC.
T13532 0-242 Sentence denotes The calcineurin inhibitors cyclosporin A and FK506 also downregulated the IL-17 secretion as well as the mitogen-activated protein kinase (MAPK) p38 inhibitor SB203580 did, whereas rapamycin and PD98059 had no effect on IL-17 levels (Fig. 3).
T133 0-242 Sentence denotes The calcineurin inhibitors cyclosporin A and FK506 also downregulated the IL-17 secretion as well as the mitogen-activated protein kinase (MAPK) p38 inhibitor SB203580 did, whereas rapamycin and PD98059 had no effect on IL-17 levels (Fig. 3).
T134 243-432 Sentence denotes To evaluate the possibility of non-specific inhibition by the drug at high concentrations, we observed the dose response of PDTC and LY294002 for the inhibition of IL-17 production in PBMC.
T135 433-526 Sentence denotes There were dose-dependent inhibitions of IL-17 production with chemical inhibitors (Fig. 4a).
T136 527-619 Sentence denotes The other inhibitors in addition to PDTC and LY294002 showed the same pattern of inhibition.
T137 620-732 Sentence denotes Cytotoxic effects on PBMC by the chemical inhibitors at experimental concentrations were not observed (Fig. 4b).

simple1

Id Subject Object Predicate Lexical cue
T13927 474-479 Protein denotes IL-17
T13926 407-412 Protein denotes IL-17
T13925 220-225 Protein denotes IL-17
T13924 74-79 Protein denotes IL-17
T13923 4-15 Protein denotes calcineurin

DLUT931

Id Subject Object Predicate Lexical cue
T14000 459-470 Negative_regulation denotes inhibitions
T13999 480-490 Gene_expression denotes production
T13998 393-403 Negative_regulation denotes inhibition
T13997 413-423 Gene_expression denotes production
T13996 56-69 Negative_regulation denotes downregulated
T13995 80-89 Localization denotes secretion
T13994 16-26 Negative_regulation denotes inhibitors
T13983 474-479 Protein denotes IL-17
T13982 407-412 Protein denotes IL-17
T13981 220-225 Protein denotes IL-17
T13980 74-79 Protein denotes IL-17
T13979 4-15 Protein denotes calcineurin
R7611 T13979 T13994 themeOf calcineurin,inhibitors
R7612 T13980 T13995 themeOf IL-17,secretion
R7613 T13982 T13997 themeOf IL-17,production
R7614 T13983 T13999 themeOf IL-17,production
R7622 T13994 T13996 causeOf inhibitors,downregulated
R7623 T13995 T13996 themeOf secretion,downregulated
R7624 T13997 T13998 themeOf production,inhibition
R7625 T13999 T14000 themeOf production,inhibitions

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T14366 51-158 Negative_regulation denotes also downregulated the IL-17 secretion as well as the mitogen-activated protein kinase (MAPK) p38 inhibitor
T14364 389-431 Negative_regulation denotes the inhibition of IL-17 production in PBMC
T14363 474-525 Gene_expression denotes IL-17 production with chemical inhibitors (Fig. 4a)
T14362 70-89 Gene_expression denotes the IL-17 secretion
T14357 404-423 Gene_expression denotes of IL-17 production
T14356 105-144 Protein denotes mitogen-activated protein kinase (MAPK)
T14355 649-672 Entity denotes the chemical inhibitors
T14353 474-479 Protein denotes IL-17
T14351 527-580 Entity denotes The other inhibitors in addition to PDTC and LY294002
T14350 407-412 Protein denotes IL-17
T14348 27-40 Entity denotes cyclosporin A
T14347 376-384 Entity denotes LY294002
T14346 572-580 Entity denotes LY294002
T14345 101-158 Entity denotes the mitogen-activated protein kinase (MAPK) p38 inhibitor
T14343 0-15 Protein denotes The calcineurin
T14341 101-158 Protein denotes the mitogen-activated protein kinase (MAPK) p38 inhibitor
T14340 74-79 Protein denotes IL-17
T14335 641-645 Entity denotes PBMC
T14332 496-525 Entity denotes chemical inhibitors (Fig. 4a)
T14331 298-309 Entity denotes by the drug
T14326 427-431 Entity denotes PBMC
T14325 139-143 Protein denotes MAPK
T14324 195-202 Entity denotes PD98059
T14323 220-225 Protein denotes IL-17
T14318 181-190 Entity denotes rapamycin
T14317 274-286 Entity denotes non-specific
R7925 T14340 T14362 themeOf IL-17,the IL-17 secretion
R7928 T14350 T14357 themeOf IL-17,of IL-17 production
R7929 T14353 T14363 themeOf IL-17,IL-17 production with chemical inhibitors (Fig. 4a)
R7931 T14357 T14364 themeOf of IL-17 production,the inhibition of IL-17 production in PBMC
R7935 T14362 T14366 themeOf the IL-17 secretion,also downregulated the IL-17 secretion as well as the mitogen-activated protein kinase (MAPK) p38 inhibitor

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T14273 731-732 . denotes .
T14272 730-731 -RRB- denotes )
T14271 728-730 CD denotes 4b
T14270 723-727 NNP denotes Fig.
T14269 722-723 -LRB- denotes (
T14217 393-403 NN denotes inhibition
T14216 389-392 DT denotes the
T14215 385-388 IN denotes for
T14214 376-384 NNP denotes LY294002
T14213 372-375 CC denotes and
T14212 367-371 NNP denotes PDTC
T14211 364-366 IN denotes of
T14210 355-363 NN denotes response
T14209 350-354 NN denotes dose
T14208 346-349 DT denotes the
T14207 337-345 VBD denotes observed
T14206 334-336 PRP denotes we
T14205 332-333 , denotes ,
T14204 318-332 NNS denotes concentrations
T14203 313-317 JJ denotes high
T14202 310-312 IN denotes at
T14201 305-309 NN denotes drug
T14200 301-304 DT denotes the
T14199 298-300 IN denotes by
T14198 287-297 NN denotes inhibition
T14197 274-286 JJ denotes non-specific
T14196 271-273 IN denotes of
T14195 259-270 NN denotes possibility
T14194 255-258 DT denotes the
T14193 246-254 VB denotes evaluate
T14192 243-245 TO denotes To
T14191 241-242 . denotes .
T14190 240-241 -RRB- denotes )
T14189 239-240 CD denotes 3
T14188 234-238 JJ denotes Fig.
T14187 233-234 -LRB- denotes (
T14186 226-232 NNS denotes levels
T14185 220-225 NN denotes IL-17
T14184 217-219 IN denotes on
T14183 210-216 NN denotes effect
T14182 207-209 DT denotes no
T14181 203-206 VBD denotes had
T14180 195-202 NNP denotes PD98059
T14179 191-194 CC denotes and
T14178 181-190 NN denotes rapamycin
T14177 173-180 IN denotes whereas
T14176 171-172 , denotes ,
T14175 168-171 VBD denotes did
T14174 159-167 CD denotes SB203580
T14173 149-158 NN denotes inhibitor
T14172 145-148 CD denotes p38
T14171 143-144 -RRB- denotes )
T14170 139-143 NNP denotes MAPK
T14169 138-139 -LRB- denotes (
T14168 131-137 NN denotes kinase
T14167 123-130 NN denotes protein
T14166 105-122 JJ denotes mitogen-activated
T14165 101-104 DT denotes the
T14164 98-100 IN denotes as
T14163 93-97 RB denotes well
T14162 90-92 RB denotes as
T14161 80-89 NN denotes secretion
T14160 74-79 NNP denotes IL-17
T14159 70-73 DT denotes the
T14158 56-69 VBD denotes downregulated
T14157 51-55 RB denotes also
T14156 45-50 NNP denotes FK506
T14155 41-44 CC denotes and
T14154 39-40 DT denotes A
T14153 27-38 VBP denotes cyclosporin
T14152 16-26 NNS denotes inhibitors
T14151 4-15 NN denotes calcineurin
T14150 0-3 DT denotes The
T14218 404-406 IN denotes of
T14268 713-721 JJ denotes observed
T14267 709-712 RB denotes not
T14266 704-708 VBD denotes were
T14265 689-703 NNS denotes concentrations
T14264 676-688 JJ denotes experimental
T14263 673-675 IN denotes at
T14262 662-672 NNS denotes inhibitors
T14261 653-661 NN denotes chemical
T14260 649-652 DT denotes the
T14259 646-648 IN denotes by
T14258 641-645 NNP denotes PBMC
T14257 638-640 IN denotes on
T14256 630-637 NNS denotes effects
T14255 620-629 JJ denotes Cytotoxic
T14254 618-619 . denotes .
T14253 608-618 NN denotes inhibition
T14252 605-607 IN denotes of
T14251 597-604 NN denotes pattern
T14250 592-596 JJ denotes same
T14249 588-591 DT denotes the
T14248 581-587 VBD denotes showed
T14247 572-580 NNP denotes LY294002
T14246 568-571 CC denotes and
T14245 563-567 NNP denotes PDTC
T14244 560-562 TO denotes to
T14243 551-559 NN denotes addition
T14242 548-550 IN denotes in
T14241 537-547 NNS denotes inhibitors
T14240 531-536 JJ denotes other
T14239 527-530 DT denotes The
T14238 525-526 . denotes .
T14237 524-525 -RRB- denotes )
T14236 522-524 CD denotes 4a
T14235 517-521 NNP denotes Fig.
T14234 516-517 -LRB- denotes (
T14233 505-515 NNS denotes inhibitors
T14232 496-504 NN denotes chemical
T14231 491-495 IN denotes with
T14230 480-490 NN denotes production
T14229 474-479 JJ denotes IL-17
T14228 471-473 IN denotes of
T14227 459-470 NNS denotes inhibitions
T14226 444-458 JJ denotes dose-dependent
T14225 439-443 VBD denotes were
T14224 433-438 EX denotes There
T14223 431-432 . denotes .
T14222 427-431 NNP denotes PBMC
T14221 424-426 IN denotes in
T14220 413-423 NN denotes production
T14219 407-412 JJ denotes IL-17
R7803 T14187 T14188 punct (,Fig.
R7804 T14188 T14186 appos Fig.,levels
R7805 T14189 T14188 nummod 3,Fig.
R7806 T14190 T14188 punct ),Fig.
R7807 T14191 T14153 punct .,cyclosporin
R7808 T14192 T14193 aux To,evaluate
R7809 T14193 T14207 advcl evaluate,observed
R7810 T14194 T14195 det the,possibility
R7811 T14195 T14193 dobj possibility,evaluate
R7847 T14231 T14227 prep with,inhibitions
R7848 T14232 T14233 compound chemical,inhibitors
R7849 T14233 T14231 pobj inhibitors,with
R7850 T14234 T14235 punct (,Fig.
R7851 T14235 T14227 appos Fig.,inhibitions
R7852 T14236 T14235 nummod 4a,Fig.
R7853 T14237 T14235 punct ),Fig.
R7854 T14238 T14225 punct .,were
R7855 T14239 T14241 det The,inhibitors
R7856 T14240 T14241 amod other,inhibitors
R7857 T14241 T14248 nsubj inhibitors,showed
R7858 T14242 T14241 prep in,inhibitors
R7859 T14243 T14242 pobj addition,in
R7860 T14244 T14243 prep to,addition
R7861 T14245 T14244 pobj PDTC,to
R7862 T14246 T14245 cc and,PDTC
R7863 T14247 T14245 conj LY294002,PDTC
R7864 T14248 T14248 ROOT showed,showed
R7865 T14249 T14251 det the,pattern
R7866 T14250 T14251 amod same,pattern
R7867 T14251 T14248 dobj pattern,showed
R7868 T14252 T14251 prep of,pattern
R7869 T14253 T14252 pobj inhibition,of
R7870 T14254 T14248 punct .,showed
R7871 T14255 T14256 amod Cytotoxic,effects
R7872 T14256 T14266 nsubj effects,were
R7873 T14257 T14256 prep on,effects
R7874 T14258 T14257 pobj PBMC,on
R7875 T14259 T14256 prep by,effects
R7876 T14260 T14262 det the,inhibitors
R7877 T14261 T14262 compound chemical,inhibitors
R7878 T14262 T14259 pobj inhibitors,by
R7879 T14263 T14262 prep at,inhibitors
R7880 T14264 T14265 amod experimental,concentrations
R7881 T14265 T14263 pobj concentrations,at
R7882 T14266 T14266 ROOT were,were
R7883 T14267 T14266 neg not,were
R7884 T14268 T14266 acomp observed,were
R7885 T14269 T14268 punct (,observed
R7886 T14270 T14272 nmod Fig.,)
R7887 T14271 T14270 nummod 4b,Fig.
R7888 T14272 T14268 punct ),observed
R7889 T14273 T14266 punct .,were
R7766 T14150 T14152 det The,inhibitors
R7767 T14151 T14152 compound calcineurin,inhibitors
R7768 T14152 T14153 nsubj inhibitors,cyclosporin
R7769 T14153 T14153 ROOT cyclosporin,cyclosporin
R7770 T14154 T14153 dobj A,cyclosporin
R7771 T14155 T14154 cc and,A
R7772 T14156 T14158 nsubj FK506,downregulated
R7773 T14157 T14158 advmod also,downregulated
R7774 T14158 T14153 ccomp downregulated,cyclosporin
R7775 T14159 T14161 det the,secretion
R7776 T14160 T14161 compound IL-17,secretion
R7777 T14161 T14158 dobj secretion,downregulated
R7778 T14162 T14164 advmod as,as
R7779 T14163 T14164 advmod well,as
R7780 T14164 T14161 cc as,secretion
R7781 T14165 T14167 det the,protein
R7782 T14166 T14167 amod mitogen-activated,protein
R7783 T14167 T14168 compound protein,kinase
R7784 T14168 T14161 conj kinase,secretion
R7785 T14169 T14170 punct (,MAPK
R7786 T14170 T14168 appos MAPK,kinase
R7787 T14171 T14170 punct ),MAPK
R7788 T14172 T14175 nummod p38,did
R7789 T14173 T14175 nsubj inhibitor,did
R7790 T14174 T14173 nummod SB203580,inhibitor
R7791 T14175 T14158 conj did,downregulated
R7792 T14176 T14175 punct ",",did
R7793 T14177 T14181 mark whereas,had
R7794 T14178 T14181 nsubj rapamycin,had
R7795 T14179 T14178 cc and,rapamycin
R7796 T14180 T14178 conj PD98059,rapamycin
R7797 T14181 T14175 advcl had,did
R7798 T14182 T14183 det no,effect
R7799 T14183 T14181 dobj effect,had
R7800 T14184 T14183 prep on,effect
R7801 T14185 T14186 compound IL-17,levels
R7802 T14186 T14184 pobj levels,on
R7812 T14196 T14195 prep of,possibility
R7813 T14197 T14198 amod non-specific,inhibition
R7814 T14198 T14196 pobj inhibition,of
R7815 T14199 T14193 prep by,evaluate
R7816 T14200 T14201 det the,drug
R7817 T14201 T14199 pobj drug,by
R7818 T14202 T14193 prep at,evaluate
R7819 T14203 T14204 amod high,concentrations
R7820 T14204 T14202 pobj concentrations,at
R7821 T14205 T14207 punct ",",observed
R7822 T14206 T14207 nsubj we,observed
R7823 T14207 T14207 ROOT observed,observed
R7824 T14208 T14210 det the,response
R7825 T14209 T14210 compound dose,response
R7826 T14210 T14207 dobj response,observed
R7827 T14211 T14210 prep of,response
R7828 T14212 T14211 pobj PDTC,of
R7829 T14213 T14212 cc and,PDTC
R7830 T14214 T14212 conj LY294002,PDTC
R7831 T14215 T14210 prep for,response
R7832 T14216 T14217 det the,inhibition
R7833 T14217 T14215 pobj inhibition,for
R7834 T14218 T14217 prep of,inhibition
R7835 T14219 T14220 amod IL-17,production
R7836 T14220 T14218 pobj production,of
R7837 T14221 T14220 prep in,production
R7838 T14222 T14221 pobj PBMC,in
R7839 T14223 T14207 punct .,observed
R7840 T14224 T14225 expl There,were
R7841 T14225 T14225 ROOT were,were
R7842 T14226 T14227 amod dose-dependent,inhibitions
R7843 T14227 T14225 attr inhibitions,were
R7844 T14228 T14227 prep of,inhibitions
R7845 T14229 T14230 compound IL-17,production
R7846 T14230 T14228 pobj production,of

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T13891 139-143 Protein denotes MAPK
T13890 105-137 Protein denotes mitogen-activated protein kinase
T13889 74-79 Protein denotes IL-17
T13888 4-15 Protein denotes calcineurin
T13918 630-637 Regulation denotes effects
T13917 723-730 Protein denotes Fig. 4b
T13916 517-524 Protein denotes Fig. 4a
T13915 393-403 Negative_regulation denotes inhibition
T13914 413-423 Gene_expression denotes production
T13913 407-412 Protein denotes IL-17
T13912 56-69 Negative_regulation denotes downregulated
T13911 56-69 Negative_regulation denotes downregulated
T13910 56-69 Negative_regulation denotes downregulated
T13909 56-69 Negative_regulation denotes downregulated
T13908 210-216 Regulation denotes effect
T13907 149-158 Negative_regulation denotes inhibitor
T13906 149-158 Negative_regulation denotes inhibitor
T13905 149-158 Negative_regulation denotes inhibitor
T13904 149-158 Negative_regulation denotes inhibitor
T13903 149-158 Negative_regulation denotes inhibitor
T13902 149-158 Negative_regulation denotes inhibitor
T13901 149-158 Negative_regulation denotes inhibitor
T13900 80-89 Localization denotes secretion
T13899 80-89 Localization denotes secretion
T13898 80-89 Localization denotes secretion
T13897 80-89 Localization denotes secretion
T13896 56-69 Negative_regulation denotes downregulated
T13895 56-69 Negative_regulation denotes downregulated
T13894 16-26 Negative_regulation denotes inhibitors
T13893 220-225 Protein denotes IL-17
T13892 145-148 Protein denotes p38
R7561 T13888 T13894 themeOf calcineurin,inhibitors
R7562 T13889 T13897 themeOf IL-17,secretion
R7563 T13890 T13895 themeOf mitogen-activated protein kinase,downregulated
R7564 T13890 T13898 themeOf mitogen-activated protein kinase,secretion
R7565 T13890 T13901 themeOf mitogen-activated protein kinase,inhibitor
R7566 T13891 T13899 themeOf MAPK,secretion
R7567 T13891 T13902 themeOf MAPK,inhibitor
R7568 T13892 T13896 themeOf p38,downregulated
R7569 T13892 T13900 themeOf p38,secretion
R7570 T13892 T13903 themeOf p38,inhibitor
R7571 T13893 T13908 themeOf IL-17,effect
R7572 T13894 T13895 causeOf inhibitors,downregulated
R7573 T13894 T13896 causeOf inhibitors,downregulated
R7574 T13894 T13909 causeOf inhibitors,downregulated
R7575 T13894 T13910 causeOf inhibitors,downregulated
R7576 T13894 T13911 causeOf inhibitors,downregulated
R7577 T13894 T13912 causeOf inhibitors,downregulated
R7578 T13897 T13904 themeOf secretion,inhibitor
R7579 T13897 T13909 themeOf secretion,downregulated
R7580 T13898 T13905 themeOf secretion,inhibitor
R7581 T13898 T13910 themeOf secretion,downregulated
R7582 T13899 T13906 themeOf secretion,inhibitor
R7583 T13899 T13911 themeOf secretion,downregulated
R7584 T13900 T13907 themeOf secretion,inhibitor
R7585 T13900 T13912 themeOf secretion,downregulated
R7586 T13913 T13914 themeOf IL-17,production
R7587 T13914 T13915 themeOf production,inhibition
R7588 T13917 T13918 themeOf Fig. 4b,effects

testone

Id Subject Object Predicate Lexical cue
T13329 505-515 Negative_regulation denotes inhibitors
T13328 480-490 Gene_expression denotes production
T13327 459-470 Negative_regulation denotes inhibitions
T13326 413-423 Gene_expression denotes production
T13325 393-403 Negative_regulation denotes inhibition
T13324 210-216 Regulation denotes effect
T13323 149-158 Negative_regulation denotes inhibitor
T13322 80-89 Localization denotes secretion
T13321 56-69 Negative_regulation denotes downregulated
T13310 474-479 Protein denotes IL-17
T13309 407-412 Protein denotes IL-17
T13308 220-225 Protein denotes IL-17
T13307 74-79 Protein denotes IL-17
T13306 4-15 Protein denotes calcineurin
R7256 T13307 T13322 themeOf IL-17,secretion
R7257 T13308 T13324 causeOf IL-17,effect
R7258 T13309 T13326 themeOf IL-17,production
R7259 T13310 T13328 themeOf IL-17,production
R7266 T13322 T13321 themeOf secretion,downregulated
R7267 T13323 T13321 themeOf inhibitor,downregulated
R7268 T13326 T13325 themeOf production,inhibition
R7269 T13328 T13327 themeOf production,inhibitions
R7270 T13329 T13327 themeOf inhibitors,inhibitions